StockGlow

Denali Therapeutics Inc. (4DN.MU)

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

21.14+0.02%Healthcare
Compare 4DN.MU with
StockGlow Score
89
Bullish
BearishBullish
1 year ago+76.8%

The outlook

Denali Therapeutics Inc. currently reads as bullish based on above its 50- & 200-day averages, 81% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
$3.36B
52-wk high
23.51
52-wk low
10.92
50-day avg
19.74
200-day avg
17.10
Trailing P/E
—

Similar stocks

4DN.FDenali Therapeutics Inc.$20.72+0.00%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%2L9.FVisionWave Holdings, Inc.$1.70+0.00%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%38I.FIntellia Therapeutics, Inc.$9.30+1.53%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy